118 related articles for article (PubMed ID: 38608215)
1. Machine Learning-Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma.
Rask Kragh Jørgensen R; Bergström F; Eloranta S; Tang Severinsen M; Bjøro Smeland K; Fosså A; Haaber Christensen J; Hutchings M; Bo Dahl-Sørensen R; Kamper P; Glimelius I; E Smedby K; K Parsons S; Mae Rodday A; J Maurer M; M Evens A; C El-Galaly T; Hjort Jakobsen L
JCO Clin Cancer Inform; 2024 Apr; 8():e2300255. PubMed ID: 38608215
[TBL] [Abstract][Full Text] [Related]
2. The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium.
Rodday AM; Parsons SK; Upshaw JN; Friedberg JW; Gallamini A; Hawkes E; Hodgson D; Johnson P; Link BK; Mou E; Savage KJ; Zinzani PL; Maurer M; Evens AM
J Clin Oncol; 2023 Apr; 41(11):2076-2086. PubMed ID: 36495588
[TBL] [Abstract][Full Text] [Related]
3. A new prognostic model including platelet/lymphocyte ratio and International Prognostic Score 3 for freedom from progression in patients with previously untreated advanced classical Hodgkin lymphoma.
Tao Y; Chen H; Zhou Y; He X; Qin Y; Liu P; Zhou S; Yang J; Zhou L; Zhang C; Yang S; Gui L; Shi Y
Asia Pac J Clin Oncol; 2022 Oct; 18(5):e486-e494. PubMed ID: 35238169
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era.
Diefenbach CS; Li H; Hong F; Gordon LI; Fisher RI; Bartlett NL; Crump M; Gascoyne RD; Wagner H; Stiff PJ; Cheson BD; Stewart DA; Kahl BS; Friedberg JW; Blum KA; Habermann TM; Tuscano JM; Hoppe RT; Horning SJ; Advani RH
Br J Haematol; 2015 Nov; 171(4):530-8. PubMed ID: 26343802
[TBL] [Abstract][Full Text] [Related]
5. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
6. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
7. Optimizing Outcome Prediction in Diffuse Large B-Cell Lymphoma by Use of Machine Learning and Nationwide Lymphoma Registries: A Nordic Lymphoma Group Study.
Biccler JL; Eloranta S; de Nully Brown P; Frederiksen H; Jerkeman M; Jørgensen J; Jakobsen LH; Smedby KE; Bøgsted M; El-Galaly TC
JCO Clin Cancer Inform; 2018 Dec; 2():1-13. PubMed ID: 30652603
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Utility of the IPS 3 Score for Predicting Outcomes in Advanced Hodgkin Lymphoma.
Ganesan P; Dhanushkodi M; Ganesan TS; Radhakrishnan V; Kannan K; Sundersingh S; Sagar TG
Clin Lymphoma Myeloma Leuk; 2019 Feb; 19(2):116-122. PubMed ID: 30579722
[TBL] [Abstract][Full Text] [Related]
9. IPS-3 Validation in 1012 cases with classical hodgkin lymphoma.
Paydas S; Laçin S; Doğan M; Barista I; Yildiz B; Seydaoglu G; Karadurmus N; Civriz S; Kaplan MA; Yagci M; Gurkan E; Ercolak V
Leuk Res; 2021 Mar; 102():106519. PubMed ID: 33556744
[TBL] [Abstract][Full Text] [Related]
10. Decreased Prognostic Value of International Prognostic Score in Chinese Advanced Hodgkin Lymphoma Patients Treated in the Contemporary Era.
Wang Q; Qin Y; Kang SY; He XH; Liu P; Yang S; Zhou SY; Zhang CG; Gui L; Yang JL; Sun Y; Shi YK
Chin Med J (Engl); 2016 Dec; 129(23):2780-2785. PubMed ID: 27900988
[TBL] [Abstract][Full Text] [Related]
11. A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts.
Huet S; Tesson B; Jais JP; Feldman AL; Magnano L; Thomas E; Traverse-Glehen A; Albaud B; Carrère M; Xerri L; Ansell SM; Baseggio L; Reyes C; Tarte K; Boyault S; Haioun C; Link BK; Feugier P; Lopez-Guillermo A; Tilly H; Brice P; Hayette S; Jardin F; Offner F; Sujobert P; Gentien D; Viari A; Campo E; Cerhan JR; Salles G
Lancet Oncol; 2018 Apr; 19(4):549-561. PubMed ID: 29475724
[TBL] [Abstract][Full Text] [Related]
12. Utility of pre-treatment FDG PET/CT-derived machine learning models for outcome prediction in classical Hodgkin lymphoma.
Frood R; Clark M; Burton C; Tsoumpas C; Frangi AF; Gleeson F; Patel C; Scarsbrook A
Eur Radiol; 2022 Oct; 32(10):7237-7247. PubMed ID: 36006428
[TBL] [Abstract][Full Text] [Related]
13. Is the international prognostic score for advanced stage Hodgkin's disease applicable to early stage patients? German Hodgkin Lymphoma Study Group.
Franklin J; Paulus U; Lieberz D; Breuer K; Tesch H; Diehl V
Ann Oncol; 2000 May; 11(5):617-23. PubMed ID: 10907959
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Baseline Tumor Burden and Tumor Dissemination Extracted From 18 F-FDG PET/CT in a Cohort of Adult Patients With Early or Advanced Hodgkin Lymphoma.
Mouheb M; Pierre-Jean M; Devillers A; Fermé C; Benchalal M; Manson G; Le Jeune F; Houot R; Palard-Novello X
Clin Nucl Med; 2024 Jan; 49(1):e1-e5. PubMed ID: 38015041
[TBL] [Abstract][Full Text] [Related]
15. A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma.
Liu CJ; Lin SY; Yang CF; Yeh CM; Kuan AS; Wang HY; Tsai CK; Gau JP; Hsiao LT; Chen PM; Liu YC; Hong YC; Ko PS; Liu JH; Lin CH
Cancer Med; 2020 Mar; 9(6):2134-2145. PubMed ID: 32011103
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer.
Song J; Wang L; Ng NN; Zhao M; Shi J; Wu N; Li W; Liu Z; Yeom KW; Tian J
JAMA Netw Open; 2020 Dec; 3(12):e2030442. PubMed ID: 33331920
[TBL] [Abstract][Full Text] [Related]
17. Machine learning-based development and validation of a scoring system for progression-free survival in liver cancer.
Liu X; Hou Y; Wang X; Yu L; Wang X; Jiang L; Yang Z
Hepatol Int; 2020 Jul; 14(4):567-576. PubMed ID: 32556865
[TBL] [Abstract][Full Text] [Related]
18. Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial.
Russell J; Collins A; Fowler A; Karanth M; Saha C; Docherty S; Padayatty J; Maw K; Lentell I; Cooke L; Hodson A; Shah N; Sadullah S; Grigoropoulos N; Qian W; Kirkwood AA; Uttenthal BJ; Johnson P; Follows GA
Ann Hematol; 2021 Apr; 100(4):1049-1058. PubMed ID: 33641019
[TBL] [Abstract][Full Text] [Related]
19. Development and comparison of 1-year survival models in patients with primary bone sarcomas: External validation of a Bayesian belief network model and creation and external validation of a new gradient boosting machine model.
Holm CE; Grazal CF; Raedkjaer M; Baad-Hansen T; Nandra R; Grimer R; Forsberg JA; Petersen MM; Skovlund Soerensen M
SAGE Open Med; 2022; 10():20503121221076387. PubMed ID: 35154743
[TBL] [Abstract][Full Text] [Related]
20. Validation of the simplified International Prognostic Score3 in a Hellenic cohort of patients with advanced-stage Hodgkin-lymphoma.
Asimakopoulos JV; Angelopoulou MK; Arapaki MP; Kanellopoulos A; Dimou M; Giakoumis X; Konstantinou E; Belia M; Chatzidimitriou C; Sachanas S; Iliakis T; Kyrtsonis MC; Siakantaris MP; Viniou NA; Variamis E; Kontopidou FN; Pangalis GA; Panayiotidis P; Konstantopoulos K; Vassilakopoulos TP
Br J Haematol; 2020 Sep; 190(6):e335-e339. PubMed ID: 32602960
[No Abstract] [Full Text] [Related]
[Next] [New Search]
